Top Markets
#1 Black Phoenix Black Phoenix +354.83%
#2 Glidr Glidr +84.34%
#3 Akedo Akedo +80.06%
#4 Gold Park Gold Park +60.52%
#5 Acurast Acurast +38.24%
#6 OpenEden OpenEden +36.58%
#7 BasedHype BasedHype +27.21%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +23.14%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +20.59%
Coin of the day
Black Phoenix Black Phoenix
Ustawienia
Język
POLSKI
Waluta
USD
Motyw
Scandion Oncology A/S Scandion Oncology A/S

Scandion Oncology A/S

SCOL
Pozycja w akcjach #40631
Operating as a clinical-stage biotechnology company, Scandion Oncology A/S... Operating as a clinical-stage biotechnology company, Scandion Oncology A/S specializes in creating pharmaceutical solutions to combat resistance to chemotherapy. Their primary investigational drug, SCO-101, an orally administered compound, is currently progressing through Phase Ib and Phase II clinical studies with cancer patients. Another pipeline candidate, SCO-201, is undergoing preclinical assessment for its potential efficacy against solid tumors. Established in 2017, Scandion Oncology A/S maintains its headquarters in Copenhagen, Denmark.
Cena akcji
$0.00045794
Ostatnia synchronizacja: 2025-07-11
Kapitalizacja rynkowa
$107.51K
Zmiana (1 dzień)
-36.01%
Zmiana (1 rok)
0.00%
Kraj
DK
Handel Scandion Oncology A/S (SCOL)

Kategoria

Healthcare
Historia ceny akcji dla Scandion Oncology A/S (SCOL)
Najwyższa cena zamknięcia: $0.00 dnia 2025-07-01

Najniższa cena zamknięcia: $0.74 dnia 2018-11-01
Historia cen akcji firmy Scandion Oncology A/S od 2018 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2025 -92.13%
2024 -96.87%
2023 -14.41%
2022 -80.44%
2021 -42.28%
2020 127.83%
2019 80.43%
2018 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $517.18 30.63%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $857.76 32.66%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $744.96 8.94%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.08K -6.68%
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $259.89 16.65%
BE